Research programme: chelating agents - Ology Bioservices

Drug Profile

Research programme: chelating agents - Ology Bioservices

Alternative Names: Diethylenetriaminepentaacetate oral; DTPA oral; Pentetic acid oral

Latest Information Update: 06 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nanotherapeutics
  • Developer Ology Bioservices
  • Class Antidotes; Polyamines; Radioprotectives
  • Mechanism of Action Chelating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Radiation injuries

Most Recent Events

  • 02 Oct 2017 Nanotherapeutics is now called Ology Bioservices
  • 16 Jul 2016 No recent reports of development identified for research development in Radiation-injuries in USA (PO)
  • 29 Sep 2011 Early research in Radiation injuries in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top